Clinical Trial Update: A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR). [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating two LXE408 oral regimens versus miltefosine as an active control to assess efficacy, safety, and pharmacokinetics in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Cutaneous Leishmaniasis

Drugs mentioned

• LXE408 (LXE408)
• Miltefosine (miltefosine)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Localized Cutaneous Leishmaniasis | Phase 2 | Status: NOT_YET_RECRUITING